The Pacific Smiles Group Ltd (ASX: PSQ) share price has certainly not had the best start to the day.
In morning trade the dental centre operator’s shares are down 13% to $1.80.
This morning Pacific Smiles provided the market with a trading update. As you might have guessed, it wasn’t overly positive.
According to the release trading in April and May has been softer than expected. As a result, same centre patient fee growth is at 3.8% year-to-date, compared to its guidance for at least 5%.
Unfortunately the company appears to believe things will get worse before they get better and has revised its full-year same centre patient fee growth guidance to 3%.
Further to this, management has had to downgrade its full-year underlying EBITDA guidance to between $20.4 million and $21 million, from $21.7 million and $23.2 million.
The soft trading appears to be a nationwide trend, with management advising that no single dental centre cohort or geographic region has contributed to the decline.
In light of these weak trading conditions, I wouldn’t be surprised to see the shares of rival 1300 Smiles Limited (ASX: ONT) and dental products provider SDI Limited (ASX: SDI) also come under pressure today.
Should you invest?
Even after today’s decline Pacific Smiles’ shares are changing hands at approximately 27x trailing earnings.
I feel this is quite expensive given the soft trading environment and its current outlook.
Although a long way out still and things are likely to change, management has forecast FY 2018 EBITDA growth of around 10%. In my opinion this isn’t sufficient to justify an investment at the current share price.
Whereas these high-flying growth shares could prove to be great value for money today in my opinion. I've tipped them for big things this year.
For many, blue chip stocks means stability, profitability and regular dividends, often fully franked..
But knowing which blue chips to buy, and when, can be fraught with danger.
The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2017."
Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.
If you’re expecting to see the likes of Commonwealth Bank, Telstra and Wesfarmers shares on this list, you’ll be sorely disappointed. Not only are their dividends growing at a snail’s pace, their profits are under pressure too due to the increasing competitive environment.
The contrast to these “new breed” blue chips couldn’t be greater… especially the very real prospect of significant share price gains, something that’s looking less likely from the usual blue chip suspects.
The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.
Click here to claim your free report.
Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.